DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,444,163 | +67.8% | 306,693 | +85.4% | 0.00% | 0.0% |
Q1 2024 | $2,053,012 | -11.2% | 165,432 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $2,312,739 | -2.9% | 165,432 | +2.6% | 0.00% | 0.0% |
Q3 2023 | $2,382,134 | +84.6% | 161,282 | +22.6% | 0.00% | 0.0% |
Q2 2023 | $1,290,681 | 0.0% | 131,568 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,290,681 | +4.3% | 131,568 | +13.1% | 0.00% | 0.0% |
Q4 2022 | $1,237,986 | -99.9% | 116,352 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,214,714,000 | -17.9% | 116,352 | -1.0% | 0.00% | 0.0% |
Q2 2022 | $1,480,031,000 | +15.2% | 117,556 | -0.8% | 0.00% | 0.0% |
Q1 2022 | $1,285,179,000 | -23.0% | 118,559 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,668,126,000 | -25.9% | 118,559 | +1.1% | 0.00% | 0.0% |
Q3 2021 | $2,252,584,000 | +67.1% | 117,261 | -14.3% | 0.00% | 0.0% |
Q2 2021 | $1,348,268,000 | +15.5% | 136,880 | +15.3% | 0.00% | 0.0% |
Q1 2021 | $1,167,066,000 | +120.5% | 118,725 | -0.2% | 0.00% | – |
Q4 2020 | $529,168,000 | +56.1% | 118,914 | +51.6% | 0.00% | – |
Q3 2020 | $338,930,000 | -97.7% | 78,456 | -95.2% | 0.00% | -100.0% |
Q2 2020 | $14,638,160,000 | +151.9% | 1,650,300 | +0.3% | 0.01% | +125.0% |
Q1 2020 | $5,810,754,000 | -41.7% | 1,646,106 | -5.5% | 0.00% | -33.3% |
Q4 2019 | $9,959,126,000 | +59.4% | 1,741,106 | -0.4% | 0.01% | +50.0% |
Q3 2019 | $6,246,525,000 | -10.1% | 1,747,280 | +0.3% | 0.00% | -20.0% |
Q2 2019 | $6,950,209,000 | +10.9% | 1,741,907 | +103.2% | 0.01% | 0.0% |
Q1 2019 | $6,265,058,000 | -19.2% | 857,053 | +1.2% | 0.01% | -28.6% |
Q4 2018 | $7,752,310,000 | +13.2% | 847,247 | +53.4% | 0.01% | +40.0% |
Q3 2018 | $6,848,954,000 | -23.6% | 552,335 | -6.0% | 0.01% | -28.6% |
Q2 2018 | $8,958,917,000 | -23.6% | 587,470 | -0.6% | 0.01% | -22.2% |
Q1 2018 | $11,726,288,000 | +2422.4% | 590,745 | +2276.3% | 0.01% | – |
Q4 2017 | $464,882,000 | -95.9% | 24,860 | -95.3% | 0.00% | -100.0% |
Q3 2017 | $11,255,143,000 | +50.3% | 523,495 | -32.5% | 0.01% | +42.9% |
Q2 2017 | $7,487,696,000 | +57.6% | 775,927 | -2.8% | 0.01% | +40.0% |
Q1 2017 | $4,751,843,000 | +149989.8% | 798,629 | -0.4% | 0.01% | +25.0% |
Q4 2016 | $3,166,000 | -62.7% | 801,615 | -0.9% | 0.00% | -55.6% |
Q3 2016 | $8,483,000 | +8.1% | 808,703 | +50.2% | 0.01% | 0.0% |
Q2 2016 | $7,850,000 | -27.0% | 538,423 | -3.7% | 0.01% | -25.0% |
Q1 2016 | $10,754,000 | +2622.5% | 558,964 | +3321.5% | 0.01% | – |
Q4 2015 | $395,000 | +6.5% | 16,337 | +7.9% | 0.00% | – |
Q3 2015 | $371,000 | +75.0% | 15,137 | +67.3% | 0.00% | – |
Q2 2015 | $212,000 | – | 9,049 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |